The company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of maki...

Experience with the Omicron variant so far makes clear that while vaccines are critical for reducing the virulence of the disease, therapie...

The Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...

US drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licenc...

The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified ...

The government is likely to indemnify Pfizer Inc against future liabilities arising from adverse after-effects of its Covid-19 jabs, paving...

“India will have to give approval if it has to secure free doses of Pfizer vaccine from the Covax facility,” an official said. “Without giv...

A committee of experts is likely to meet this week to consider Pfizer Inc’s application seeking emergency use authorisation for its Covid v...

The leaders of big pharma came together for a joint press conference to give an update on the way ahead for Covid-19 treatment and vaccines...

On July 1, Pfizer increased the prices of over 40 drugs including Viagra.

Pfizer said that decision to close the plant is based on an assessment of its long term viability and its ability to achieve the needed pro...

Watson’s launch raises questions on India’s third-largest drug company Ranbaxy Laboratories’ revenues from the drug.

But for Indian companies, it was not always supposed to be like this. The end of Lipitor’s patent was meant to be a eureka moment for Ranba...

Strides Acrolabs is discussing drug supply deal for niche therapeutics areas with global drug pharma companies.

Boehringer Ingelheim in talks with Cipla for supply of generic drugs to the $17-bn German coa for two drugs.

Mumbai-based drugmaker Cipla is in talks with global pharma majors for a drug research and supply agreement, said a top company executive o...

Hit by the shortage of raw material codeine, India’s highest selling drug (in value) Pfizer’s cough syrup Corex has slipped to the eighth s...